13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001856083-26-000001
Total Value
$5.61B
Positions
55
Other Managers
0
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST | 78464A870 | 10,000,000 | $1.22B | 21.74% |
| 2 | IMMUNOVANT INC | IMVT | 11,526,971 | $293.0M | 5.22% |
| 3 | GUARDANT HEALTH INC | GH | 2,800,000 | $286.0M | 5.10% |
| 4 | STRUCTURE THERAPEUTICS INC | GPCR | 4,111,782 | $286.0M | 5.10% |
| 5 | TARSUS PHARMACEUTICALS INC | TARS | 3,004,034 | $246.0M | 4.39% |
| 6 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 15,726,349 | $241.9M | 4.31% |
| 7 | CYTOKINETICS INC | CYTK | 3,336,998 | $212.0M | 3.78% |
| 8 | AXSOME THERAPEUTICS INC | AXSM | 1,150,000 | $210.0M | 3.74% |
| 9 | APELLIS PHARMACEUTICALS INC | APLS | 7,750,000 | $194.7M | 3.47% |
| 10 | VAXCYTE INC | PCVX | 4,000,000 | $184.6M | 3.29% |
| 11 | MAZE THERAPEUTICS INC | MAZE | 4,246,440 | $175.9M | 3.14% |
| 12 | VERA THERAPEUTICS INC | VERA | 2,821,135 | $142.9M | 2.55% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2,300,000 | $136.7M | 2.44% |
| 14 | IONIS PHARMACEUTICALS INC | IONS | 1,700,000 | $134.5M | 2.40% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 7,036,455 | $133.5M | 2.38% |
| 16 | MBX BIOSCIENCES INC | MBX | 3,249,790 | $102.5M | 1.83% |
| 17 | OCULAR THERAPEUTIX INC | OCUL | 8,070,414 | $98.0M | 1.75% |
| 18 | GRAIL INC | GRAL | 1,022,797 | $87.5M | 1.56% |
| 19 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,524,833 | $78.6M | 1.40% |
| 20 | LB PHARMACEUTICALS INC | LBRX | 3,352,804 | $74.6M | 1.33% |
| 21 | IMMUNOCORE HLDGS PLC | IMCR | 2,003,978 | $69.6M | 1.24% |
| 22 | ORUKA THERAPEUTICS INC | ORKA | 2,161,510 | $65.5M | 1.17% |
| 23 | BRIDGEBIO PHARMA INC | BBIO | 810,142 | $62.0M | 1.10% |
| 24 | CORMEDIX INC | CRMD | 5,274,076 | $61.3M | 1.09% |
| 25 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 4,610,071 | $60.8M | 1.08% |
| 26 | ALKERMES PLC | ALKS | 2,000,000 | $56.0M | 1.00% |
| 27 | DYNE THERAPEUTICS INC | DYN | 2,650,000 | $51.8M | 0.92% |
| 28 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,900,738 | $51.6M | 0.92% |
| 29 | COMPASS PATHWAYS PLC | CMPS | 7,334,323 | $50.6M | 0.90% |
| 30 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,000,000 | $50.0M | 0.89% |
| 31 | SOLENO THERAPEUTICS INC | SLNO | 1,000,000 | $46.3M | 0.83% |
| 32 | VERASTEM INC | VSTM | 5,740,850 | $44.3M | 0.79% |
| 33 | BICARA THERAPEUTICS INC | BCAX | 2,614,004 | $44.0M | 0.78% |
| 34 | GERON CORP | GERN | 32,511,271 | $42.9M | 0.77% |
| 35 | ENGENE HOLDINGS INC | ENGNW | 4,377,572 | $39.5M | 0.70% |
| 36 | ANI PHARMACEUTICALS INC | ANIP | 477,684 | $37.7M | 0.67% |
| 37 | TERNS PHARMACEUTICALS INC | TERN | 769,048 | $31.1M | 0.55% |
| 38 | ENANTA PHARMACEUTICALS INC | ENTA | 1,956,867 | $30.9M | 0.55% |
| 39 | MIND MEDICINE MINDMED INC | 60255C885 | 1,676,540 | $22.4M | 0.40% |
| 40 | TANGO THERAPEUTICS INC | TNGX | 2,454,562 | $21.7M | 0.39% |
| 41 | X4 PHARMACEUTICALS INC | XFOR | 5,013,661 | $20.1M | 0.36% |
| 42 | ATAI BECKLEY NV | N0731H103 | 4,677,289 | $19.1M | 0.34% |
| 43 | XENON PHARMACEUTICALS INC | XENE | 366,435 | $16.4M | 0.29% |
| 44 | COGENT BIOSCIENCES INC | COGT | 453,102 | $16.1M | 0.29% |
| 45 | CYBIN INC | HELP | 1,854,255 | $15.2M | 0.27% |
| 46 | CONTEXT THERAPEUTICS INC | CNTX | 7,419,355 | $10.9M | 0.19% |
| 47 | MONOPAR THERAPEUTICS INC | MNPR | 95,408 | $6.2M | 0.11% |
| 48 | BIOHAVEN LTD | BHVN | 500,000 | $5.6M | 0.10% |
| 49 | CRESCENT BIOPHARMA INC. | CBIO | 453,686 | $5.4M | 0.10% |
| 50 | ALIGOS THERAPEUTICS INC | ALGS | 444,110 | $4.1M | 0.07% |
| 51 | BILLIONTOONE INC | BLLN | 50,000 | $4.1M | 0.07% |
| 52 | RAPT THERAPEUTICS INC | 75382E208 | 110,448 | $3.7M | 0.07% |
| 53 | INVENTIVA SA | IVEVF | 490,000 | $2.3M | 0.04% |
| 54 | JANUX THERAPEUTICS INC | JANX | 89,589 | $1.2M | 0.02% |
| 55 | ADLAI NORTYE LTD | ANL | 34,852 | $49,490 | 0.00% |